Products Muthesa (out of commerce) Structure and properties Oxetacaine (C28H41N3O3, Mr = 467.6 g/mol) belongs to the amide-type local anesthetics. Effects Oxetacaine (ATC C05AD06) has local anesthetic properties. Indications Symptomatic relief ulcer, gastritis, and esophagitis.
Products Stavudine is commercially available in capsule form (Zerit). It has been approved in many countries since 1996. Structure and properties Stavudine (C10H12N2O4, Mr = 224.2 g/mol) is a thymidine analog with a missing 3′-hydroxy group. It is a prodrug that is biotransformed intracellularly to the active metabolite stavudine triphosphate. Stavudine exists as a white … Stavudine
Products Dabrafenib was approved in the US and EU in 2013 and in many countries in 2014 in hard capsule form (Tafinlar). Structure and properties Dabrafenib (C23H20F3N5O2S2, Mr = 519.6 g/mol) is present in drugs as dabrafenib mesilate, a white to slightly colored powder that is practically insoluble in water. It is a thiazole and … Dabrafenib
Products Cefovecin is available as an injectable for animals. It has been approved in many countries since 2007. Structure and properties Cefovecin (C17H19N5O6S2, Mr = 453.5 g/mol) Effects Cefovecin (ATCvet QJ01DD91) has bactericidal properties with long-lasting activity against Gram-positive and Gram-negative bacteria. Indications For the treatment of bacterial infectious diseases in dogs and cats.
Products Guanethidine is no longer on the market in many countries and many others. Ismelin tablets (Ciba-Geigy) are no longer available. Structure and properties Guanethidine (C10H22N4, Mr = 198.3 g/mol) is present in drugs as guanethidine monosulfate, a white crystalline powder that is highly soluble in water. It is a guanidine derivative. Effects Guanethidine (ATC … Guanethidine
